<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li X</submitter><funding>Basic scientific research expenses for scientific research projects of universities of Heilongjiang province</funding><pagination>7784</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12948968</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>MUC14/Endomucin, a transmembrane mucin, is a potential prognostic biomarker in malignancies. This study aimed to elucidate the functional impact of MUC14 on tumor proliferation, migration, immune microenvironment modulation, and cisplatin response in lung adenocarcinoma (LUAD), and investigate its molecular mechanisms. LUAD cell lines with MUC14 overexpression (MUC14-OE) or silencing were constructed. Malignant behaviors were assessed via CCK-8, Transwell, and colony formation assays. Immune cell infiltration was quantified by CD3+/CD8 + immunohistochemistry. Subcutaneous xenograft and tail-vein metastasis murine models evaluated in vivo tumor progression and cisplatin responsiveness. Mechanisms were characterized using FRET and western blotting. Multiplatform bioinformatics analysis of pu</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>MUC14 suppresses lung adenocarcinoma via integrin α8β6/PI3K/AKT/MAPK modulating cisplatin response and immunity.</pubmed_title><pmcid>PMC12948968</pmcid><funding_grant_id>2023-KYYWF-0182</funding_grant_id><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Huang S</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Yu S</pubmed_authors><pubmed_authors>Xing C</pubmed_authors><pubmed_authors>Han G</pubmed_authors><pubmed_authors>Li M</pubmed_authors></additional><is_claimable>false</is_claimable><name>MUC14 suppresses lung adenocarcinoma via integrin α8β6/PI3K/AKT/MAPK modulating cisplatin response and immunity.</name><description>MUC14/Endomucin, a transmembrane mucin, is a potential prognostic biomarker in malignancies. This study aimed to elucidate the functional impact of MUC14 on tumor proliferation, migration, immune microenvironment modulation, and cisplatin response in lung adenocarcinoma (LUAD), and investigate its molecular mechanisms. LUAD cell lines with MUC14 overexpression (MUC14-OE) or silencing were constructed. Malignant behaviors were assessed via CCK-8, Transwell, and colony formation assays. Immune cell infiltration was quantified by CD3+/CD8 + immunohistochemistry. Subcutaneous xenograft and tail-vein metastasis murine models evaluated in vivo tumor progression and cisplatin responsiveness. Mechanisms were characterized using FRET and western blotting. Multiplatform bioinformatics analysis of pu</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T23:10:15.752Z</modification><creation>2026-07-12T03:11:17.722Z</creation></dates><accession>S-EPMC12948968</accession><cross_references><pubmed>41656379</pubmed><doi>10.1038/s41598-026-39019-z</doi></cross_references></HashMap>